AbbVie Inc.
GB ˙ LSE ˙ US00287Y1091
229,00 $ ↑6,18 (2,77%)
2026-06-05
DEL PRIS
SecurityGB:0QCV / AbbVie Inc.
InstitutionVident Advisory, LLC
Latest Disclosed Ownership176,635 shares
Latest Disclosed Value $ 38,416,553
Vident Advisory, LLC reports 16.77% increase in ownership of 0QCV / AbbVie Inc.

On May 14, 2026 - Vident Advisory, LLC filed a 13F-HR form disclosing ownership of 176,635 shares of AbbVie Inc. (GB:0QCV) valued at $38,245,010 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 151,270 shares of AbbVie Inc.. This represents a change in shares of 16.77% during the quarter. The current value of the position is $40,449,415 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 176,635 25,365 16.77 38,417 11.15 0.1039
2026-02-18 2025-12-31 13F ABBVIE COM 00287Y109 151,270 2,499 1.68 34,564 0.34 0.3147
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 148,771 5,909 4.14 34,446 29.90 0.3291
2025-08-14 2025-06-30 13F ABBVIE COM 00287Y109 142,862 8,859 6.61 26,518 -5.55 0.2977
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 134,003 41,386 44.69 28,077 70.60 0.4102
2025-02-14 2024-12-31 13F ABBVIE COM 00287Y109 92,617 15,110 19.50 16,459 7.52 0.2887
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 77,507 -5,242 -6.33 15,307 7.85 0.3852
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 82,749 -215,848 -72.29 14,193 -73.90 0.3921
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 298,597 54,803 22.48 54,375 43.92 1.1327
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 243,794 -1,062 -0.43 37,781 3.51 0.9495
2024-02-21 2023-09-30 13F/A-01 ABBVIE COM 00287Y109 244,856 244,856 36,498 1.1308
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 244,856 244,856 36,498 0.9105
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.